Acquisition of the Midbrain Dopaminergic Neuronal Identity.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Jun 2020
Historique:
received: 25 05 2020
revised: 22 06 2020
accepted: 26 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

The mesodiencephalic dopaminergic (mdDA) group of neurons comprises molecularly distinct subgroups, of which the substantia nigra (SN) and ventral tegmental area (VTA) are the best known, due to the selective degeneration of the SN during Parkinson's disease. However, although significant research has been conducted on the molecular build-up of these subsets, much is still unknown about how these subsets develop and which factors are involved in this process. In this review, we aim to describe the life of an mdDA neuron, from specification in the floor plate to differentiation into the different subsets. All mdDA neurons are born in the mesodiencephalic floor plate under the influence of both SHH-signaling, important for floor plate patterning, and WNT-signaling, involved in establishing the progenitor pool and the start of the specification of mdDA neurons. Furthermore, transcription factors, like Ngn2, Ascl1, Lmx1a, and En1, and epigenetic factors, like Ezh2, are important in the correct specification of dopamine (DA) progenitors. Later during development, mdDA neurons are further subdivided into different molecular subsets by, amongst others, Otx2, involved in the specification of subsets in the VTA, and En1, Pitx3, Lmx1a, and WNT-signaling, involved in the specification of subsets in the SN. Interestingly, factors involved in early specification in the floor plate can serve a dual function and can also be involved in subset specification. Besides the mdDA group of neurons, other systems in the embryo contain different subsets, like the immune system. Interestingly, many factors involved in the development of mdDA neurons are similarly involved in immune system development and vice versa. This indicates that similar mechanisms are used in the development of these systems, and that knowledge about the development of the immune system may hold clues for the factors involved in the development of mdDA neurons, which may be used in culture protocols for cell replacement therapies.

Identifiants

pubmed: 32629812
pii: ijms21134638
doi: 10.3390/ijms21134638
pmc: PMC7369932
pii:
doi:

Substances chimiques

Transcription Factors 0
Dopamine VTD58H1Z2X

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Rev Neurosci. 2001 Feb;2(2):99-108
pubmed: 11253000
Development. 2007 Jul;134(14):2673-84
pubmed: 17592014
Brain Res. 2015 May 22;1608:40-50
pubmed: 25747864
Stem Cells. 2009 Dec;27(12):2917-27
pubmed: 19725118
Development. 2015 Apr 1;142(7):1315-24
pubmed: 25804738
J Biol Chem. 2015 Jul 10;290(28):17401-14
pubmed: 26023233
Cell Rep. 2020 May 5;31(5):107601
pubmed: 32375051
Nature. 1996 Sep 26;383(6598):332-4
pubmed: 8848044
Front Mol Neurosci. 2017 Nov 01;10:353
pubmed: 29163030
Immunity. 2012 Mar 23;36(3):348-61
pubmed: 22425249
Brain Res Dev Brain Res. 1995 May 26;86(1-2):101-13
pubmed: 7544698
Development. 1999 Feb;126(5):945-59
pubmed: 9927596
Exp Brain Res. 1995;105(2):191-9
pubmed: 7498372
Int J Dev Biol. 2017;61(3-4-5):257-265
pubmed: 27528042
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12747-52
pubmed: 14557550
Mol Cell Neurosci. 2015 Sep;68:131-42
pubmed: 26164566
Biol Open. 2012 Aug 15;1(8):693-704
pubmed: 23213462
Dev Biol. 2005 Jun 15;282(2):467-79
pubmed: 15950611
Development. 2013 Aug;140(16):3373-84
pubmed: 23863478
Semin Immunopathol. 2008 Dec;30(4):383-98
pubmed: 18925397
Cell. 2006 Jan 27;124(2):393-405
pubmed: 16439212
Nat Rev Neurosci. 2007 Jan;8(1):21-32
pubmed: 17180160
J Neurosci. 2008 Apr 2;28(14):3644-56
pubmed: 18385323
Stem Cells Dev. 2014 Mar 1;23(5):477-87
pubmed: 24172139
Curr Opin Immunol. 2000 Apr;12(2):151-8
pubmed: 10712946
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):697-702
pubmed: 26833176
Nature. 1999 Sep 9;401(6749):161-4
pubmed: 10490024
Biol Open. 2016 Feb 15;5(3):279-88
pubmed: 26879466
PLoS One. 2013 Oct 07;8(10):e76037
pubmed: 24116087
Cell Tissue Res. 2015 Jan;359(1):65-85
pubmed: 25367430
Cell. 1998 May 29;93(5):755-66
pubmed: 9630220
Genes Brain Behav. 2016 Jan;15(1):62-73
pubmed: 26548362
Mol Immunol. 2008 Jun;45(11):3302-11
pubmed: 18384878
Mol Cell Neurosci. 2005 Jan;28(1):96-105
pubmed: 15607945
Curr Opin Cell Biol. 2000 Dec;12(6):736-41
pubmed: 11063941
Mol Biol Cell. 2009 Feb;20(3):924-36
pubmed: 19056682
Immunity. 2013 Aug 22;39(2):298-310
pubmed: 23954131
Stem Cell Reports. 2018 Sep 11;11(3):651-664
pubmed: 30146491
Exp Neurol. 2007 Feb;203(2):394-405
pubmed: 17034791
Dev Biol. 2013 Jan 1;373(1):176-83
pubmed: 23117062
Trends Neurosci. 2020 Mar;43(3):155-169
pubmed: 32101709
Development. 2004 Apr;131(8):1663-77
pubmed: 15084453
J Biol Chem. 2010 Mar 5;285(10):7246-53
pubmed: 20018874
Cell. 2016 Oct 6;167(2):566-580.e19
pubmed: 27716510
Front Mol Neurosci. 2019 Apr 09;12:76
pubmed: 31024250
PLoS One. 2013 Sep 16;8(9):e74049
pubmed: 24066094
Neuron. 2004 Aug 5;43(3):345-57
pubmed: 15294143
Front Mol Neurosci. 2019 Jan 17;11:491
pubmed: 30705619
Eur J Immunol. 2008 Jul;38(7):1788-94
pubmed: 18581335
Brain Struct Funct. 2013 Sep;218(5):1229-77
pubmed: 23052546
Stem Cell Reports. 2017 Sep 12;9(3):779-795
pubmed: 28803914
Brain Res Gene Expr Patterns. 2002 Jan;1(2):115-21
pubmed: 15018808
Genes Dev. 1995 Dec 15;9(24):3136-48
pubmed: 8543157
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4013-8
pubmed: 9520484
Cell. 1995 Jan 13;80(1):95-101
pubmed: 7813022
J Cell Biochem. 2010 Apr 1;109(5):844-9
pubmed: 20069555
Nat Commun. 2019 Feb 4;10(1):581
pubmed: 30718509
Nat Neurosci. 2016 Aug 26;19(9):1131-41
pubmed: 27571192
Mol Immunol. 2017 May;85:47-56
pubmed: 28208073
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Neuroscience. 2006 Nov 3;142(4):1119-31
pubmed: 16920270
Eur J Neurosci. 2003 Oct;18(7):1731-8
pubmed: 14622207
Exp Neurol. 2016 Sep;283(Pt A):235-45
pubmed: 27317298
Development. 2001 Dec;128(23):4789-800
pubmed: 11731459
Development. 2006 Jan;133(1):89-98
pubmed: 16339193
eNeuro. 2016 Jul 13;3(3):
pubmed: 27419218
J Immunol. 2007 May 1;178(9):5717-26
pubmed: 17442955
Cell Mol Life Sci. 2014 Dec;71(24):4703-27
pubmed: 25064061
Neurogenesis (Austin). 2015 Mar 09;2(1):e998101
pubmed: 27502145
Dis Model Mech. 2011 May;4(3):368-80
pubmed: 21183473
Development. 2004 Mar;131(5):1145-55
pubmed: 14973278
PLoS One. 2008;3(10):e3517
pubmed: 18953410
J Neuroimmune Pharmacol. 2012 Dec;7(4):750-62
pubmed: 22535304
J Dev Biol. 2019 Jan 15;7(1):
pubmed: 30650592
Exp Neurol. 2012 Jul;236(1):58-68
pubmed: 22524988
Curr Opin Genet Dev. 2002 Aug;12(4):409-15
pubmed: 12100885
Development. 2006 May;133(9):1799-809
pubmed: 16571630
FEBS Lett. 2015 Dec 21;589(24 Pt A):3773-85
pubmed: 26431946
J Immunol. 2019 Feb 1;202(3):966-978
pubmed: 30567730
Stem Cell Reports. 2018 Apr 10;10(4):1237-1250
pubmed: 29526736
Dev Dyn. 2010 Jan;239(1):237-45
pubmed: 19795512
PLoS One. 2014 May 27;9(5):e97926
pubmed: 24865218
Front Mol Neurosci. 2017 Jan 13;9:166
pubmed: 28133444
Exp Cell Res. 2007 Apr 1;313(6):1172-80
pubmed: 17291494
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40
pubmed: 20061006
Nat Neurosci. 2001 Dec;4(12):1175-81
pubmed: 11704761
Development. 2004 May;131(9):2037-48
pubmed: 15105370
Mol Brain. 2019 Dec 11;12(1):110
pubmed: 31829254
Development. 1997 Aug;124(15):2923-34
pubmed: 9247335
Development. 2006 Feb;133(3):495-505
pubmed: 16410412
Exp Neurol. 2006 Mar;198(1):183-98
pubmed: 16438966
Cell Cycle. 2012 Jan 1;11(1):26-32
pubmed: 22157093
J Exp Med. 2019 Apr 1;216(4):884-899
pubmed: 30898894
Development. 2011 Aug;138(16):3399-408
pubmed: 21752929
J Neurosci. 2011 Aug 31;31(35):12413-25
pubmed: 21880902
Immunol Res. 2011 Apr;49(1-3):202-15
pubmed: 21128008
J Mol Cell Biol. 2014 Feb;6(1):27-33
pubmed: 24287202
Development. 2006 Feb;133(3):507-16
pubmed: 16396906
Development. 2011 Dec;138(23):5213-22
pubmed: 22069189
Nat Rev Immunol. 2007 Sep;7(9):726-35
pubmed: 17690714
Trends Neurosci. 2005 Feb;28(2):62-5; discussion 65-6
pubmed: 15667926
Neuroscience. 2019 Nov 21;421:176-191
pubmed: 31672641
Development. 2007 Jan;134(2):317-25
pubmed: 17166916
J Immunol. 2018 Oct 15;201(8):2193-2200
pubmed: 30301837
FEBS Lett. 2015 Dec 21;589(24 Pt A):3727-38
pubmed: 26526610
Cell Rep. 2014 Aug 21;8(4):1018-25
pubmed: 25127144
Gene Expr Patterns. 2018 Jan;27:8-15
pubmed: 28958789
Eur J Neurosci. 2013 Jan;37(1):23-32
pubmed: 23106268
Development. 2015 Jun 1;142(11):2069-79
pubmed: 25977363
Development. 1998 Aug;125(15):2759-70
pubmed: 9655799
Blood. 2009 May 21;113(21):5144-56
pubmed: 19273836
Immunity. 2000 Aug;13(2):187-97
pubmed: 10981962
Dev Dyn. 2010 Jan;239(1):211-21
pubmed: 19795519
J Neurosci. 2005 May 11;25(19):4856-67
pubmed: 15888661
Brain Res Mol Brain Res. 1995 Mar;29(1):107-18
pubmed: 7769987
Sci Rep. 2017 Jul 20;7(1):6036
pubmed: 28729666
Elife. 2019 Jan 28;8:
pubmed: 30689541
PLoS One. 2017 Aug 11;12(8):e0182421
pubmed: 28800615
Biochem Cell Biol. 2000;78(5):577-84
pubmed: 11103948
Nat Neurosci. 2010 Dec;13(12):1481-8
pubmed: 21057506
Trends Mol Med. 2003 Mar;9(3):126-32
pubmed: 12657434
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2905-14
pubmed: 23858460
Cell. 1995 May 5;81(3):445-55
pubmed: 7736596
Nat Neurosci. 2009 Feb;12(2):125-31
pubmed: 19122665
Development. 2007 Sep;134(17):3213-25
pubmed: 17670789
Genes Dev. 2010 Jun 1;24(11):1186-200
pubmed: 20516201
Blood. 2007 May 1;109(9):3757-66
pubmed: 17227833
PLoS One. 2011 Feb 11;6(2):e15786
pubmed: 21347250
Development. 2009 Feb;136(4):531-40
pubmed: 19144721

Auteurs

Simone Mesman (S)

Swammerdam Institute for Life Sciences, FNWI, University of Amsterdam, 1098 XH Amsterdam, The Netherlands.

Marten P Smidt (MP)

Swammerdam Institute for Life Sciences, FNWI, University of Amsterdam, 1098 XH Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH